Gene · 23345
Papers2,274
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,274
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effective TME-related signature to predict prognosis of patients with head and neck squamous cell carcinoma. | Front Mol Biosci | 2023 | 37670814 | PubTator, text mining | PubMed |
| Small extrachromosomal circular DNAs as biomarkers for multi-cancer diagnosis and monitoring. | Clin Transl Med | 2023 | 37649244 | PubTator, text mining | PubMed |
| Targeting Duchenne muscular dystrophy by skipping DMD exon 45 with base editors. | Mol Ther Nucleic Acids | 2023 | 37637209 | PubTator, text mining | PubMed |
| A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged Periodic Fasting. | Medicina (Kaunas) | 2023 | 37629695 | PubTator, text mining | PubMed |
| Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer. | Int J Mol Sci | 2023 | 37629096 | PubTator, text mining | PubMed |
| Puzzling Out the Genetic Architecture of Endometriosis: Whole-Exome Sequencing and Novel Candidate Gene Identification in a Deeply Clinically Characterised Cohort. | Biomedicines | 2023 | 37626618 | PubTator, text mining | PubMed |
| Somatic mutation effects diffused over microRNA dysregulation. | Bioinformatics | 2023 | 37624931 | PubTator, text mining | PubMed |
| The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma. | Front Immunol | 2023 | 37600770 | PubTator, text mining | PubMed |
The implication of necroptosis-related lncRNAs in orchestrating immune infiltration and predicting therapeutic efficacy in colon adenocarcinoma: an integrated bioinformatic analysis with preliminarily experimental validation. | Front Genet | 2023 | 37600653 | PubTator, text mining | PubMed |
| Genomic properties and clinical outcomes associated with tertiary lymphoid structures in patients with breast cancer. | Sci Rep | 2023 | 37598257 | PubTator, text mining | PubMed |
| Tumor microenvironment characterization in colorectal cancer to identify prognostic and immunotherapy genes signature. | BMC Cancer | 2023 | 37596528 | PubTator, text mining | PubMed |
| A novel disulfidptosis and glycolysis related risk score signature for prediction of prognosis and ICI therapeutic responsiveness in colorectal cancer. | Sci Rep | 2023 | 37587262 | PubTator, text mining | PubMed |
| Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers. | NPJ Precis Oncol | 2023 | 37558751 | PubTator, text mining | PubMed |
| Molecular characteristics of gastric cancer with ERBB2 amplification. | Heliyon | 2023 | 37554835 | PubTator, text mining | PubMed |
| Prognostic-related genes for pancreatic cancer typing and immunotherapy response prediction based on single-cell sequencing data and bulk sequencing data. | Oncol Res | 2023 | 37547756 | PubTator, text mining | PubMed |
| A Common Genetic Factor Underlies Genetic Risk for Gynaecological and Reproductive Disorders and Is Correlated with Risk to Depression. | Neuroendocrinology | 2023 | 37544299 | PubTator, text mining | PubMed |
| Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma. | Genes (Basel) | 2023 | 37510286 | PubTator, text mining | PubMed |
| Senescence-based colorectal cancer subtyping reveals distinct molecular characteristics and therapeutic strategies. | MedComm (2020) | 2023 | 37502611 | PubTator, text mining | PubMed |
| Fluid Overload-Associated Large B-Cell Lymphoma: A Case Report and Review of Literature. | Hematol Rep | 2023 | 37489372 | PubTator, text mining | PubMed |
| Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data. | Aging (Albany NY) | 2023 | 37480572 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23345/papers?page=12